Global X - Genomics & Biotechnology ETF (GNOM) Stock Overview
Explore Global X - Genomics & Biotechnology ETF’s financial performance, market position, analyst ratings, and future outlook.
Global X - Genomics & Biotechnology ETF (GNOM)
Key Financials
Key Financials
Market Cap
95.3M
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
0.00%
GNOM Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Global X - Genomics & Biotechnology ETF (NASDAQ: GNOM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Global X - Genomics & Biotechnology ETF's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of GNOM on the NASDAQ shows an RSI of 67.59, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $77.07 for the NASDAQ listing.
Key metrics behind Global X - Genomics & Biotechnology ETF's NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 95.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of GNOM on the NASDAQ.